BRCA2 and ovarian carcinoma: The BRCAness phenotype could be explained in part by miRNA (dys-) regulation of BRCA2. Previous studies linked BRCA2’s post-transcriptional regulation by miRNAs to breast and ovarian cancer cell lines (Song et al., 2012; Choi et al., 2014).